Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 21, 2010; 16(27): 3437-3444
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3437
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3437
Variable | Hazard ratio | 95% CI | P value |
Treatment regimen (ADM vs DDPH) | 0.329 | 0.149-0.726 | 0.006 |
Gender (female vs male) | 2.291 | 1.174-4.470 | 0.015 |
Number of tumors (1-3 vs≥ 4) | 6.541 | 3.201-13.363 | < 0.001 |
PVTT (Vp0-2 vs Vp3) | 6.704 | 2.581-17.418 | < 0.001 |
Albumin ( ≤ 3.5 g/dL vs > 3.5 g/dL) | 0.311 | 0.157-0.612 | 0.001 |
- Citation: Kasai K, Ushio A, Sawara K, Miyamoto Y, Kasai Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K. Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2010; 16(27): 3437-3444
- URL: https://www.wjgnet.com/1007-9327/full/v16/i27/3437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i27.3437